Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 10

    Otsuka enters deal with Mylan for Deltyba to treat MDR-TB

    Otsuka enters deal with Mylan for Deltyba to treat MDR-TB

    Ruby Khatun Khatun27 Aug 2017 11:00 AM IST
    TOKYO, HERTFORDSHIRE, England, and PITTSBURGH: Otsuka Pharmaceutical Co. Ltd. and Mylan NV have entered into a license agreement between their...
    LifeCell launches improved and advanced umbilical cord stem cell collection kit

    LifeCell launches improved and advanced umbilical cord stem cell collection kit

    Ruby Khatun Khatun20 Aug 2017 9:45 AM IST
    CHENNAI: Most expectant parents draw a checklist of things that need to be taken to the hospital at the time of delivery. The most important thing out...
    Columbia Clinic by Columbia Asia Hospitals Launched at Embassy TechVillage in Bangalore

    Columbia Clinic by Columbia Asia Hospitals Launched at Embassy TechVillage in Bangalore

    Ruby Khatun Khatun19 Aug 2017 9:45 AM IST
    BENGALURU: Over the last two decades there has been an alarming rise in cardiovascular diseases, diabetes, hypertension, asthma and respiratory...
    Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

    Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

    supriya kashyap kashyap17 Aug 2017 12:09 PM IST
    New Delhi : Johnson & Johnson Private Limited today announced a new partnership with the Institute of Microbial Technology (IMTECH), part of the...
    Gilead announces USFDA Priority Review Designation for FDC of Bictegravir, Emtricitabine, Tenofovir Alafenamide to treat HIV

    Gilead announces USFDA Priority Review Designation for FDC of Bictegravir, Emtricitabine, Tenofovir Alafenamide to treat HIV

    Ruby Khatun Khatun15 Aug 2017 10:15 AM IST
    FOSTER CITY, Calif: Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New...
    Boehringer Ingelheim achieves good growth in the first half of 2017

    Boehringer Ingelheim achieves good growth in the first half of 2017

    Ruby Khatun Khatun15 Aug 2017 9:45 AM IST
    Ingelheim, Germany: Boehringer Ingelheim has delivered positive results for the first half of 2017. Net sales increased by 24 per cent on the same...
    FDA advisory committee votes in favor of tofacitinib citrate for the treatment of active psoriatic arthritis

    FDA advisory committee votes in favor of tofacitinib citrate for the treatment of active psoriatic arthritis

    Ruby Khatun Khatun14 Aug 2017 10:15 AM IST
    NEW YORK: Pfizer Inc. announced that the United States Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10 to 1 to...
    LifeCell Becomes Indias Biggest Cord Blood Stem Cell Registry for Unrelated Use

    LifeCell Becomes Indias Biggest Cord Blood Stem Cell Registry for Unrelated Use

    Ruby Khatun Khatun12 Aug 2017 9:20 AM IST
    Achieves landmark milestone within four months of launch of revolutionary banking modelCHENNAI: In spite of being a highly populated country, India...
    Mylan Launches Avonza in India for HIV

    Mylan Launches Avonza in India for HIV

    Ruby Khatun Khatun10 Aug 2017 10:00 AM IST
    HERTFORDSHIRE, England and PITTSBURGH: Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., a leading global pharmaceutical company, has...
    Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration

    Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration

    Ruby Khatun Khatun6 Aug 2017 9:16 AM IST
    New York & Boulder, Colo.: Bristol-Myers Squibb Company and Clovis Oncology, Inc. announced the companies have entered into a clinical...
    Nalinikanth Gollagunta appointed as President and CEO of GE Healthcare India, South Asia

    Nalinikanth Gollagunta appointed as President and CEO of GE Healthcare India, South Asia

    Ruby Khatun Khatun3 Aug 2017 9:30 AM IST
    Bangalore: GE Healthcare announced the appointment of Nalinikanth (Nal) Gollagunta as President and CEO, GE Healthcare India and South Asia and...
    AIOCD ties-up with JIO to launch JIO-GST for Chemists and Druggists

    AIOCD ties-up with JIO to launch JIO-GST for Chemists and Druggists

    Ruby Khatun Khatun31 July 2017 3:32 PM IST
    All India Organisation of Chemists and Druggists (AIOCD) has partnered with Jio to introduce JioGST, a simple & secure GST compliance solution,...
    PrevNext

    Popular Stories

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

    HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Health Insurance- The Best Backup Plan in Today

    Health Insurance- The Best Backup Plan in Today's Times

    Coronavirus Update: Sanitizers, surgical masks, n95 masks, gloves brought under Essential Commodities Act

    Coronavirus Update: Sanitizers, surgical masks, n95 masks, gloves brought under Essential...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok